ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 247 filers reported holding ICU MED INC in Q4 2022. The put-call ratio across all filers is 4.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $494,880 | -37.2% | 3,000 | -40.0% | 0.18% | -55.3% |
| Q4 2022 | $787,400 | -65.1% | 5,000 | -66.7% | 0.40% | -69.5% |
| Q3 2022 | $2,259,000 | +5.7% | 15,000 | +15.4% | 1.33% | +7.3% |
| Q2 2022 | $2,137,000 | -73.8% | 13,000 | -62.9% | 1.24% | -52.1% |
| Q3 2021 | $8,168,000 | +16.7% | 35,000 | +2.9% | 2.58% | +30.1% |
| Q2 2021 | $6,997,000 | -51.3% | 34,000 | -51.4% | 1.98% | -32.8% |
| Q1 2021 | $14,381,000 | -6.9% | 70,000 | -4.1% | 2.95% | -8.4% |
| Q4 2020 | $15,452,000 | +38.6% | 73,000 | +19.7% | 3.22% | -6.3% |
| Q3 2020 | $11,148,000 | -22.5% | 61,000 | -21.8% | 3.44% | -14.1% |
| Q2 2020 | $14,376,000 | +547.9% | 78,000 | +609.1% | 4.00% | +376.4% |
| Q1 2020 | $2,219,000 | -82.9% | 11,000 | -84.3% | 0.84% | -71.7% |
| Q4 2019 | $12,985,000 | +132.5% | 70,000 | +100.0% | 2.97% | +103.8% |
| Q3 2019 | $5,586,000 | – | 35,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |